rabeprazole has been researched along with gastrins in 34 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 9 (26.47) | 18.2507 |
| 2000's | 21 (61.76) | 29.6817 |
| 2010's | 4 (11.76) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Harada, Y; Ikeda, H; Kawai, T; Saitou, T | 1 |
| Aoki, T; Higashimoto, Y; Kanayama, S; Miwa, K; Miyazaki, I; Miyazaki, Y; Narita, T; Okuda, Y; Shinomura, Y; Yasunaga, Y | 1 |
| Aoki, T; Fukui, H; Higashimoto, Y; Imamura, I; Miwa, K; Miyazaki, I; Miyazaki, Y; Narita, T; Okuda, Y; Shinomura, Y | 1 |
| Greenwood, B; Humphries, TJ; Maton, PN; Robinson, M; Rodriguez, S | 1 |
| Bassion, S; Cloud, ML; Enas, N; Humphries, TJ | 1 |
| Barbuti, RC; Humphries, TJ; Kovacs, TO; Lew, EA; Sytnic, B; Walsh, JH | 1 |
| Hamilton, MI; Pounder, RE; Sercombe, J; Williams, MP | 1 |
| Beker, JA; Bell, NE; Dekkers, CP; Gabryelewicz, A; Humphries, TJ; Thjodleifsson, B | 1 |
| Robinson, M | 1 |
| Maeyama, K; Matsui, H; Nakamura, S; Onji, M; Watanabe, H; Yokota, T | 1 |
| Blanshard, C; Millson, C; Pounder, RE; Sercombe, J; Williams, MP | 1 |
| Farley, A; Humphries, TJ; Wruble, LD | 1 |
| Furuie, H; Horai, Y; Irie, S; Ishizaki, T; Kimura, M; Koga, Y; Matsuguma, K; Matsui, T; Murakami, M; Nagahama, T; Urae, A; Yao, T | 1 |
| Sheptulin, AA | 1 |
| Fukushima, Y; Hasegawa, J; Ieiri, I; Ishizaki, T; Kishimoto, Y; Kitano, M; Momiyama, K; Morisawa, T; Morita, T; Nakagawa, K; Okochi, H; Otsubo, K | 1 |
| Carswell, CI; Goa, KL | 1 |
| Haruma, K; Kajiyama, G; Kawano, M; Kodama, K; Okahara, S; Sumii, K; Tari, A; Yonei, Y | 1 |
| Sugano, K | 1 |
| Baisley, K; Boyce, M; Miller, N; Morocutti, A; Tejura, B; Warrington, S | 1 |
| Bardhan, KD; Fiocca, R; Humphries, TJ; Miller, N; Morocutti, A; Rindi, G; Thjodleifsson, B | 1 |
| Chilton, A; Nwokolo, CU; Pounder, RE; Sercombe, J; Usselmann, B; Williams, MP | 1 |
| Chern, HD; Lin, CJ; Uang, YS; Wang, TH; Yang, JC | 1 |
| Maeyama, K; Matsui, H; Matsuura, B; Onji, M; Yokota, T | 1 |
| Fiocca, R; Jacobs, A; Miller, N; Morocutti, A; Rindi, G; Thjodleifsson, B | 1 |
| Barth, J; Breiter, J; Caos, A; Perdomo, C | 1 |
| Hashimoto, H; Hirota, K; Kudo, M; Kushikata, T | 1 |
| Ariizumi, K; Eda, Y; Iijima, K; Inomata, Y; Kawamura, M; Kayaba, S; Koike, T; Noguchi, M; Ohara, S; Sekine, H; Shimosegawa, T; Sugiyama, K | 1 |
| Hu, NZ; Hu, XP; Hu, YM; Mei, Q; Xu, JM; Xu, XH | 1 |
| Boyer, K; Tolia, V | 1 |
| Anjiki, H; Hattori, K; Ishii, T; Kuyama, Y; Sanaka, M; Yamamoto, T | 1 |
| Fujimoto, K; Hongo, M | 1 |
| Hu, P; Sloan, S; Treem, W | 1 |
| Black, J; Boyce, M; Chen, D; Dowen, S; Turnbull, G; van den Berg, F; Zhao, CM | 1 |
| Abe, H; Fujishiro, M; Fukushima, Y; Hojo, S; Kato, M; Kinoshita, Y; Kumagai, S; Kusano, M; Masuyama, H; Nakata, R; Okubo, Y | 1 |
3 review(s) available for rabeprazole and gastrins
| Article | Year |
|---|---|
Review article: current perspectives on hypergastrinaemia and enterochromaffin-like-cell hyperplasia.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Ulcer Agents; Benzimidazoles; Enterochromaffin-like Cells; Enzyme Inhibitors; Gastrins; Humans; Hyperplasia; Omeprazole; Rabeprazole | 1999 |
[Safety profile of pariet clinical use (a literature review)].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Benzimidazoles; Drug Interactions; Enzyme Inhibitors; Gastric Mucosa; Gastrins; Humans; Neoplasms; Omeprazole; Proton-Translocating ATPases; Rabeprazole | 2001 |
Rabeprazole: an update of its use in acid-related disorders.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Aryl Hydrocarbon Hydroxylases; Benzimidazoles; Cytochrome P-450 Enzyme System; Drug Administration Schedule; Drug Costs; Drug Interactions; Duodenal Ulcer; Gastrins; Gastroesophageal Reflux; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Rabeprazole; Steroid 16-alpha-Hydroxylase; Steroid Hydroxylases; Stomach Ulcer; Zollinger-Ellison Syndrome | 2001 |
21 trial(s) available for rabeprazole and gastrins
| Article | Year |
|---|---|
Effects of oral rabeprazole on oesophageal and gastric pH in patients with gastro-oesophageal reflux disease.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Benzimidazoles; Cross-Over Studies; Double-Blind Method; Enzyme Inhibitors; Esophagitis, Peptic; Female; Gastric Acid; Gastric Acidity Determination; Gastric Mucosa; Gastrins; Humans; Hydrogen-Ion Concentration; Male; Omeprazole; Proton Pump Inhibitors; Rabeprazole | 1997 |
Rabeprazole in treatment of acid peptic diseases: results of three placebo-controlled dose-response clinical trials in duodenal ulcer, gastric ulcer, and gastroesophageal reflux disease (GERD). The Rabeprazole Study Group.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Breath Tests; Dose-Response Relationship, Drug; Double-Blind Method; Duodenal Ulcer; Enzyme Inhibitors; Female; Gastrins; Gastroesophageal Reflux; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Proton-Translocating ATPases; Rabeprazole; Stomach Ulcer; Treatment Outcome | 1998 |
An ascending single-dose safety and tolerance study of an oral formulation of rabeprazole (E3810).
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adult; Anti-Ulcer Agents; Area Under Curve; Benzimidazoles; Dose-Response Relationship, Drug; Double-Blind Method; Gastric Acid; Gastrins; Half-Life; Humans; Hydrogen-Ion Concentration; Male; Omeprazole; Proton Pump Inhibitors; Rabeprazole | 1998 |
A placebo-controlled trial to assess the effects of 8 days of dosing with rabeprazole versus omeprazole on 24-h intragastric acidity and plasma gastrin concentrations in young healthy male subjects.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenosine Triphosphatases; Adult; Anti-Ulcer Agents; Area Under Curve; Benzimidazoles; Cross-Over Studies; Double-Blind Method; Gastric Acidity Determination; Gastric Mucosa; Gastrins; Humans; Hydrogen-Ion Concentration; Male; Omeprazole; Rabeprazole; Radioimmunoassay; Statistics, Nonparametric | 1998 |
Comparison of rabeprazole 20 mg versus omeprazole 20 mg in the treatment of active duodenal ulcer: a European multicentre study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Ulcer Agents; Benzimidazoles; Double-Blind Method; Duodenal Ulcer; Female; Gastrins; Humans; Male; Middle Aged; Omeprazole; Rabeprazole | 1999 |
A placebo-controlled study to assess the effects of 7-day dosing with 10, 20 and 40 mg rabeprazole on 24-h intragastric acidity and plasma gastrin in healthy male subjects.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Benzimidazoles; Cross-Over Studies; Double-Blind Method; Gastric Acid; Gastric Acidity Determination; Gastrins; Humans; Hydrogen-Ion Concentration; Male; Omeprazole; Rabeprazole; Stomach Ulcer; Treatment Outcome | 2000 |
Rabeprazole versus ranitidine for the treatment of erosive gastroesophageal reflux disease: a double-blind, randomized clinical trial. Raberprazole Study Group.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Antacids; Benzimidazoles; Double-Blind Method; Female; Gastrins; Gastroesophageal Reflux; Heartburn; Histamine H2 Antagonists; Humans; Male; Middle Aged; Omeprazole; Proton Pump Inhibitors; Rabeprazole; Ranitidine; Treatment Outcome | 2000 |
Pharmacodynamic effects and kinetic disposition of rabeprazole in relation to CYP2C19 genotypes.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adult; Anti-Ulcer Agents; Area Under Curve; Aryl Hydrocarbon Hydroxylases; Benzimidazoles; Cross-Over Studies; Cytochrome P-450 CYP2C19; Cytochrome P-450 Enzyme System; Female; Gastric Acidity Determination; Gastrins; Genotype; Helicobacter Infections; Humans; Male; Mixed Function Oxygenases; Omeprazole; Polymorphism, Genetic; Rabeprazole | 2001 |
Comparison of the kinetic disposition of and serum gastrin change by lansoprazole versus rabeprazole during an 8-day dosing scheme in relation to CYP2C19 polymorphism.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenosine Triphosphatases; Adult; Anti-Ulcer Agents; Area Under Curve; Aryl Hydrocarbon Hydroxylases; Benzimidazoles; Cross-Over Studies; Cytochrome P-450 CYP2C19; Cytochrome P-450 Enzyme System; Female; Gastrins; Genotype; Humans; Lansoprazole; Male; Mixed Function Oxygenases; Omeprazole; Polymorphism, Genetic; Proton Pump Inhibitors; Proton-Translocating ATPases; Rabeprazole | 2001 |
Effects of rabeprazole, 20 mg, or esomeprazole, 20 mg, on 24-h intragastric pH and serum gastrin in healthy subjects.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Analysis of Variance; Anti-Ulcer Agents; Benzimidazoles; Circadian Rhythm; Cross-Over Studies; Enzyme Inhibitors; Esomeprazole; Female; Gastric Acid; Gastric Acidity Determination; Gastrins; Humans; Hydrogen-Ion Concentration; Male; Middle Aged; Proton Pump Inhibitors; Rabeprazole | 2002 |
A randomized, double-blind trial of the efficacy and safety of 10 or 20 mg rabeprazole compared with 20 mg omeprazole in the maintenance of gastro-oesophageal reflux disease over 5 years.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Ulcer Agents; Benzimidazoles; Dose-Response Relationship, Drug; Double-Blind Method; Female; Gastrins; Gastroesophageal Reflux; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Prospective Studies; Rabeprazole; Recurrence; Treatment Outcome | 2003 |
Eradication of Helicobacter pylori increases nocturnal intragastric acidity during dosing with rabeprazole, omeprazole, lansoprazole and placebo.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Benzimidazoles; Breath Tests; Cross-Over Studies; Female; Gastric Acid; Gastrins; Helicobacter Infections; Helicobacter pylori; Humans; Hydrogen-Ion Concentration; Lansoprazole; Male; Omeprazole; Rabeprazole; Urea | 2003 |
Effects of 5 years of treatment with rabeprazole or omeprazole on the gastric mucosa.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Ulcer Agents; Benzimidazoles; Biopsy; Disease Progression; Dose-Response Relationship, Drug; Double-Blind Method; Female; Gastric Mucosa; Gastrins; Gastritis; Gastroesophageal Reflux; Helicobacter Infections; Helicobacter pylori; Humans; Hyperplasia; Male; Metaplasia; Middle Aged; Omeprazole; Prospective Studies; Proton Pump Inhibitors; Rabeprazole; Severity of Illness Index | 2005 |
Long-term prevention of erosive or ulcerative gastro-oesophageal reflux disease relapse with rabeprazole 10 or 20 mg vs. placebo: results of a 5-year study in the United States.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Anti-Ulcer Agents; Benzimidazoles; Dose-Response Relationship, Drug; Double-Blind Method; Esophagitis, Peptic; Female; Gastrins; Gastroesophageal Reflux; Humans; Male; Middle Aged; Omeprazole; Patient Compliance; Proton Pump Inhibitors; Rabeprazole; Secondary Prevention; Treatment Outcome | 2005 |
Therapeutic effects of 10 mg/day rabeprazole administration on reflux esophagitis was not influenced by the CYP2C19 polymorphism.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP2C19; Enzyme Inhibitors; Esophagitis, Peptic; Female; Gastrins; Helicobacter Infections; Hernia, Hiatal; Humans; Male; Middle Aged; Mixed Function Oxygenases; Pepsinogens; Polymorphism, Genetic; Prospective Studies; Rabeprazole; Wound Healing | 2006 |
Pharmacodynamic and kinetic effect of rabeprazole on serum gastrin level in relation to CYP2C19 polymorphism in Chinese Hans.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Aryl Hydrocarbon Hydroxylases; Asian People; Benzimidazoles; China; Cytochrome P-450 CYP2C19; Dose-Response Relationship, Drug; Gastrins; Genotype; Humans; Hydrogen-Ion Concentration; Male; Metabolism; Mixed Function Oxygenases; Omeprazole; Polymorphism, Restriction Fragment Length; Rabeprazole; Stomach | 2006 |
No relationship between plasma desacyl-ghrelin levels and rabeprazole-related delay in gastric emptying : controlled study in healthy volunteers.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adult; Breath Tests; Carbon Dioxide; Carbon Isotopes; Gastric Emptying; Gastrins; Ghrelin; Half-Life; Humans; Male; Middle Aged; Proton Pump Inhibitors; Rabeprazole; Statistics, Nonparametric | 2008 |
Safety and efficacy of long-term maintenance therapy with oral dose of rabeprazole 10 mg once daily in Japanese patients with reflux esophagitis.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Aged; Dose-Response Relationship, Drug; Esophagitis, Peptic; Female; Gastric Mucosa; Gastrins; Gastroesophageal Reflux; Humans; Japan; Longitudinal Studies; Male; Middle Aged; Prevalence; Prospective Studies; Proton Pump Inhibitors; Rabeprazole; Treatment Outcome | 2011 |
Normal and proton pump inhibitor-mediated gastrin levels in infants 1 to 11 months old.
Topics: Gastrins; Gastroesophageal Reflux; Histamine H2 Antagonists; Humans; Infant; Infant, Newborn; Proton Pump Inhibitors; Rabeprazole; Reference Values | 2013 |
Effect of netazepide, a gastrin/CCK2 receptor antagonist, on gastric acid secretion and rabeprazole-induced hypergastrinaemia in healthy subjects.
Topics: Adult; Aged; Benzodiazepinones; Double-Blind Method; Drug Therapy, Combination; Female; Gastric Acid; Gastric Mucosa; Gastrins; Healthy Volunteers; Humans; Hyperplasia; Male; Middle Aged; Phenylurea Compounds; Rabeprazole; Receptor, Cholecystokinin B; Stomach; Young Adult | 2015 |
Efficacy and safety of twice-daily rabeprazole maintenance therapy for patients with reflux esophagitis refractory to standard once-daily proton pump inhibitor: the Japan-based EXTEND study.
Topics: Aged; Anti-Ulcer Agents; Double-Blind Method; Drug Administration Schedule; Drug Resistance; Endoscopy; Esophagitis, Peptic; Female; Gastrins; Gastroesophageal Reflux; Humans; Japan; Kaplan-Meier Estimate; Male; Middle Aged; Polyps; Proton Pump Inhibitors; Rabeprazole; Recurrence; Secondary Prevention; Treatment Outcome | 2018 |
10 other study(ies) available for rabeprazole and gastrins
| Article | Year |
|---|---|
[Changes in the rat stomach after long-term administration of proton pump inhibitors (AG-1749 and E-3810)].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenosine Triphosphatases; Animals; Benzimidazoles; Gastric Acid; Gastrins; H(+)-K(+)-Exchanging ATPase; Lansoprazole; Male; Omeprazole; Parietal Cells, Gastric; Rabeprazole; Rats; Rats, Inbred Strains; Stomach; Vacuoles | 1992 |
Effect of antrectomy and drug-induced achlorhydria on urinary excretion of N-terminal big gastrin immunoreactivity in rats.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Achlorhydria; Animals; Benzimidazoles; Female; Gastrectomy; Gastrins; Omeprazole; Peptide Fragments; Protein Precursors; Proton Pump Inhibitors; Pyloric Antrum; Rabeprazole; Rats; Rats, Sprague-Dawley | 1993 |
Mobilization of gastric histamine during repeated administration of a proton potassium adenosine triphosphatase inhibitor in intact and antrectomized rats.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenosine Triphosphatases; Animals; Benzimidazoles; Cell Count; Enzyme Inhibitors; Female; Gastric Mucosa; Gastrins; Histamine; Histamine Release; Histidine Decarboxylase; Hormones; Injections, Subcutaneous; Omeprazole; Parietal Cells, Gastric; Protein Precursors; Pyloric Antrum; Rabeprazole; Random Allocation; Rats; Rats, Sprague-Dawley | 1995 |
Effect of rabeprazole on histamine synthesis in enterochromaffin-like cells of mast cell-deficient (Ws/Ws) rats.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Benzimidazoles; Cell Division; Enterochromaffin Cells; Enzyme Inhibitors; Gastric Acid; Gastric Mucosa; Gastrins; Histamine; Histidine Decarboxylase; Male; Mast Cells; Omeprazole; Proton Pump Inhibitors; Rabeprazole; Rats; Rats, Wistar | 2000 |
The effects of rabeprazole on parietal cells and enterochromaffin-like cells in rats: a comparison with omeprazole.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Ulcer Agents; Benzimidazoles; Drug Therapy, Combination; Enterochromaffin-like Cells; Gastrins; Histamine; Male; Models, Animal; Omeprazole; Parietal Cells, Gastric; Rabeprazole; Rats; Rats, Wistar; Stomach | 2002 |
Rabeprazole: quest for the best PPI.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Ulcer Agents; Benzimidazoles; Enterochromaffin Cells; Gastrins; Humans; Omeprazole; Parietal Cells, Gastric; Rabeprazole; Rats | 2002 |
Time-dependent amplified pharmacokinetic and pharmacodynamic responses of rabeprazole in cytochrome P450 2C19 poor metabolizers.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Academic Medical Centers; Adult; Aryl Hydrocarbon Hydroxylases; Benzimidazoles; Breath Tests; Cytochrome P-450 CYP2C19; Female; Gastrins; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Inactivation, Metabolic; Male; Mixed Function Oxygenases; Omeprazole; Prospective Studies; Proton Pump Inhibitors; Rabeprazole; Taiwan; Time Factors | 2003 |
Direct effects of proton pump inhibitors on histamine release from rat enterochromaffin-like cells.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Benzimidazoles; Cells, Cultured; Dose-Response Relationship, Drug; Enterochromaffin-like Cells; Gastrins; Histamine Release; Male; Membrane Glycoproteins; Membrane Transport Proteins; Neuropeptides; Omeprazole; Proton Pump Inhibitors; Proton Pumps; Rabeprazole; Rats; Rats, Sprague-Dawley; Vesicular Biogenic Amine Transport Proteins; Vesicular Monoamine Transport Proteins | 2003 |
The efficacy of preanesthetic proton pump inhibitor treatment for patients on long-term H2 antagonist therapy.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Ulcer Agents; Benzimidazoles; Drug Tolerance; Famotidine; Female; Gastric Acidity Determination; Gastrins; Histamine H2 Antagonists; Humans; Male; Middle Aged; Omeprazole; Piperidines; Pneumonia, Aspiration; Preanesthetic Medication; Proton Pump Inhibitors; Rabeprazole | 2005 |
Long-term proton pump inhibitor use in children: a retrospective review of safety.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Child; Child, Preschool; Esophagitis; Female; Gastrins; Humans; Lansoprazole; Liver Function Tests; Male; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rabeprazole; Retrospective Studies; Vitamin B 12 | 2008 |